NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that multiple ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. We live in an increasing data-rich world, where forward-thinking organizations are harnessing the ...
– Breadth of Alto’s pipeline and Precision Psychiatry Platform™ will be highlighted across twelve posters and presentations at the Society of Biological Psychiatry and American Society of Clinical ...
Perspective Therapeutics announced data presentations at ASCO 2025 for its cancer treatment programs [212Pb]VMT-α-NET and [212Pb]VMT01. Perspective Therapeutics, Inc. announced that it will present ...
Featuring Alexandra Samuel, speaker, researcher, and author of Work Smarter with Social Media and of the HBR article “How to Give a Data-Heavy Presentation.” Data storytelling has become a powerful ...
Most of us have sat through at least one classic data-laden presentation. The collated packet. The endless decks of "spreadsheet on a slide." They're deathly boring, and worse, they're usually ...
NOVATO, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare ...
For the past few years, hordes of putative experts have encouraged business presenters to employ more storytelling and less data. ‘Data is boring,’ they say, ‘but when you tell a good a story, people ...
- Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r - - Axatilimab abstracts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback